China and South Korea's Diverging Poultry Vaccination Policies Are Reshaping East Asia's Trade Risk
As highly pathogenic avian influenza becomes a near-permanent feature of East Asia's poultry sector, countries are splitting between vaccination and culling strategies. That divide is starting to determine who keeps export access and who doesn't.
Highly pathogenic avian influenza has cycled through East Asia's poultry sector often enough in the past decade that it no longer reads as an emergency to the region's health ministries so much as a recurring cost of doing business. What has changed is how governments are choosing to manage that cost. China has leaned further into large-scale poultry vaccination to keep flocks productive and export volumes stable. South Korea and Japan have stayed closer to a stamping-out model, built around rapid culling and movement restrictions. Both approaches are defensible on the science. The problem is that they are no longer just domestic policy choices, they are starting to determine which countries keep uninterrupted access to which export markets.
Vaccination solves a production problem and creates a surveillance one
Vaccinating commercial flocks reduces mortality and keeps farms operating through outbreak waves that would otherwise trigger mass culling. For a poultry sector as large as China's, that stability matters enormously to food security and rural livelihoods. But vaccination also suppresses the clinical symptoms that make infected birds easy to spot, which means detecting silent viral circulation in vaccinated flocks requires a much more rigorous, and more expensive, surveillance system than detecting disease in unvaccinated ones.
Trading partners know this, and it shapes how they treat imports. Countries that rely on stamping-out policies have started applying more skepticism to poultry and poultry product imports from vaccinating countries, not because vaccination is unsound science, but because verifying the surveillance behind it requires a level of transparency and third-party access that isn't yet standard across the region.
The trade risk is now a diplomatic project, not a veterinary one
Resolving this divide doesn't require picking a winner between vaccination and culling. It requires building the kind of mutual surveillance verification agreements that let a vaccinating country prove its flocks are genuinely clean, and let an importing country trust that proof without re-litigating the underlying strategy every time an outbreak makes headlines. That is fundamentally a diplomatic negotiation over data sharing standards, inspection access, and dispute resolution, layered on top of a veterinary question.
The regional bodies best positioned to broker this, APEC's agricultural working groups and bilateral veterinary agreements between China, Japan, and South Korea, have the technical relationships already in place. What's been missing is a forcing function to move from technical dialogue to a binding verification framework before the next outbreak wave turns a trade disagreement into a market closure.
Waiting for the next wave is the expensive option
Every outbreak cycle without a resolved verification framework pushes the two camps further apart, as each side accumulates specific grievances about the other's transparency that make the next negotiation harder, not easier. The countries that get ahead of this, building joint surveillance verification now, while trade volumes are stable, will avoid the abrupt market closures that have hit poultry exporters in past outbreak years. The ones that wait will be negotiating a trade dispute and a disease outbreak at the same time, which is a considerably worse position to negotiate from.